tiprankstipranks
Trending News
More News >
Innate Pharma (IPHA)
NASDAQ:IPHA

Innate Pharma (IPHA) Similar Stocks

Compare
130 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$1.81
$169.49M
-2.95
-18.52%
2 Buy
1 Hold
0 Sell
Moderate Buy
SELLAS Life Sciences Group
$1.91
$300.55M
-8.16
160.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Sangamo Biosciences
$0.44
$147.45M
-0.97
-81.70%
1 Buy
2 Hold
0 Sell
Moderate Buy
Genfit SA
$5.42
$219.11M
55.01%
2 Buy
0 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$7.87
$137.64M
-2.35
58.22%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$12.80
$312.45M
-0.03
-27.81%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
1.76
-0.40
-18.52%
SLS
SELLAS Life Sciences Group
2.34
1.44
160.00%
SGMO
Sangamo Biosciences
0.43
-1.88
-81.39%
GNFT
Genfit SA
5.88
2.16
58.06%
ELTX
Elicio Therapeutics
7.99
2.91
57.28%
VOR
Vor Biopharma
12.80
-4.93
-27.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts